Highlights
- Esperion Therapeutics Presents Full Results of Phase 2 Clinical Trial Showing Its Novel Oral...
May 2, 2013 - Esperion Therapeutics Completes $33 Million Preferred Financing to Advance Its Novel Oral...
April 26, 2013 - Esperion announces positive topline results from a Phase 2 clinical...
January 7, 2013
